Research map: FabI-targeting pentacyclic triterpenoid celastrol resensitizes multidrug-resistant Gram-negative bacteria to polymyxins

Back to the article

Papers in this map

  1. Accurate structure prediction of biomolecular interactions with AlphaFold 3 · Josh Abramson · 2024 · 16046 citations · Cited by this paper
  2. Targeting KIF11 degradation: Oxypeucedanin inhibits lung adenocarcinoma progression by disrupting the MCM2-CDK1 signaling pathway · 2026 · Related
  3. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products · Kirill A. Datsenko · 2000 · 15462 citations · Cited by this paper
  4. Chaihu-Guizhi Decoction and Saikosaponin D alleviate anxiety-like behavior by engaging HTR2C-related neurotrophic and excitatory synaptic homeostasis · 2026 · Related
  5. Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method · Ting‐Chao Chou · 2010 · 5857 citations · Cited by this paper
  6. Targeting TOM70 crotonylation to improve hypoxic vascular dysfunction: A new strategy for treating myocardial infarction · 2026 · Related
  7. Efficient evaluation of electrostatic potential with computerized optimized code · Jun Zhang · 2021 · 2659 citations · Cited by this paper
  8. Structural analysis and anti-alcoholic liver disease effects of a polysaccharide from Arundo donax L. rhizome · 2026 · Related
  9. iProX: an integrated proteome resource · Jie Ma · 2018 · 2125 citations · Cited by this paper
  10. Target discovery-directed pharmacological mechanism elucidation of bioactive natural products · 2025 · Related
  11. Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial Infections · M. E. Falagas · 2005 · 1756 citations · Cited by this paper
  12. Licochalcone C suppresses gastric cancer progression and enhances 5-FU chemosensitivity by targeting RAC3-mediated PI3K-AKT-mTOR signaling · 2026 · Related
  13. iProX in 2021: connecting proteomics data sharing with big data · Tao Chen · 2021 · 1201 citations · Cited by this paper
  14. Sinomenine alleviates chronic inflammatory pain through DNA methyltransferase 1-mediated DNA methylation of the P2X2 purinergic receptor: an epigenetic mechanism of analgesia · 2026 · Related
  15. Target identification using drug affinity responsive target stability (DARTS) · Brett Lomenick · 2009 · 1119 citations · Cited by this paper
  16. Curculigoside A alleviates metabolic dysfunction-associated steatohepatitis by targeting Rab30 to improve lipid homeostasis · 2026 · Related
  17. Triclosan targets lipid synthesis · Laura M. McMurry · 1998 · 1034 citations · Cited by this paper
  18. Tanshinone I as a novel ferritinophagy inducer triggers ferroptosis to suppress gastric cancer growth · 2026 · Related
  19. Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease · Dick de Zeeuw · 2013 · 1025 citations · Cited by this paper
  20. Ubiquitin-proteasome-dependent degradation of HIF-1α by cannabidiol disrupts pro-angiogenic synoviocyte-endothelial crosstalk in rheumatoid arthritis · 2026 · Related
  21. Predictive compound accumulation rules yield a broad-spectrum antibiotic · Michelle F. Richter · 2017 · 914 citations · Cited by this paper
  22. Colistin and its role in the Era of antibiotic resistance: an extended review (2000–2019) · Mohamed Abd El-Gawad El-Sayed Ahmed · 2020 · 776 citations · Cited by this paper
  23. The global preclinical antibacterial pipeline · Ursula Theuretzbacher · 2019 · 760 citations · Cited by this paper
  24. ESKAPEing the labyrinth of antibacterial discovery · Rubén Tommasi · 2015 · 632 citations · Cited by this paper
  25. Antimicrobial resistance: a concise update · Charlotte Shan Ho · 2024 · 614 citations · Cited by this paper
  26. Natural products: A lead for drug discovery and development · Bhawna Chopra · 2021 · 468 citations · Cited by this paper
  27. Expression of flagella is coincident with uropathogenic Escherichia coli ascension to the upper urinary tract · M. Chelsea Lane · 2007 · 432 citations · Cited by this paper
  28. Rescuing the Last-Line Polymyxins: Achievements and Challenges · Sue C. Nang · 2021 · 430 citations · Cited by this paper
  29. Enzymic Characterization of the Target for Isoniazid in Mycobacterium tuberculosis · Annaı̈k Quémard · 1995 · 373 citations · Cited by this paper
  30. Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus · Roger L. Nation · 2014 · 359 citations · Cited by this paper
  31. Influence of Test Conditions on Antifungal Time-Kill Curve Results: Proposal for Standardized Methods · Michael E. Klepser · 1998 · 344 citations · Cited by this paper
  32. Multidrug-resistant Gram-negative bacterial infections · Nenad Maćešić · 2025 · 311 citations · Cited by this paper
  33. Evolutionary Mechanisms Shaping the Maintenance of Antibiotic Resistance · Paulo Durão · 2018 · 295 citations · Cited by this paper
  34. Synthetic Oleanane and Ursane Triterpenoids with Modified Rings A and C: A Series of Highly Active Inhibitors of Nitric Oxide Production in Mouse Macrophages · Tadashi Honda · 2000 · 240 citations · Cited by this paper
  35. Natural products of pentacyclic triterpenoids: from discovery to heterologous biosynthesis · Yanlin Li · 2022 · 239 citations · Cited by this paper
  36. Rapid Detection of Polymyxin Resistance inEnterobacteriaceae · Patrice Nordmann · 2016 · 211 citations · Cited by this paper
  37. Transformation with katG restores isoniazid‐sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations · Ying Zhang · 1993 · 179 citations · Cited by this paper
  38. Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia · David R. Lynch · 2018 · 174 citations · Cited by this paper
  39. Discovery of a Novel and Potent Class of FabI-Directed Antibacterial Agents · David J Payne · 2002 · 169 citations · Cited by this paper

Source: OpenAlex (CC0)